PROS1 and COVID-19: The approved viral vector vaccines are based on a recombinant adenovirus expressing the S protein and include the Oxford–AstraZeneca (AZD1222, approved only by EMA) and the Janssen COVID-19 (approved by both EMA and FDA) vaccines [6,7].